Search

EgeUn###, Purpose: We aimed to investigate the effect of percutaneous nephrostomy (PCN) implementation on the second ureteroscopy (URS) outcomes after a failed URS. Materials and Methods: The data of four hundred forty-eight patients with an unsuccessful URS history were evaluated. Patients were divided into two groups; patients who underwent PCN before second URS (Group A) and patients who did not (Group B). We compared the stone access rate in the second URS between the two groups according to patient and stone characteristics and operative data. Then, group A was subdivided into two groups according to stone access as; access succeeded (Group A1) and access failed (Group A2). We also compared stone access rates between these two groups in terms of gender, age, body mass index, stone size, side, location, grade of hydronephrosis and PCN duration. All data were available immediately after surgery and obtained from patient files and the outcome assessment was performed during the study period. Results: Stone access rate was higher in group A than group B (143/196 vs 41/252, P = .0018). Mean nephrostomy duration and mean hydronephrosis grade were significantly higher and mean stone size was significantly lower in group A1 than group A2 (18.74 vs 9.62 days, P < .001; grade 3.25 vs 1.21, P = .038; and 7.286 vs 12.631 mm P < .001, respectively). Conclusion: PCN is a favourable intervention after a failed URS and increases the success rate of the second operation with ease of implementation and minimal morbidity.

WOS: 000444494100002, Objective: In addition to ensuring cancer control, prevention of incontinence and erectile dysfunction, which significantly impact patients' quality of life, is also an important issue in robot-assisted laparoscopic radical prostatectomy (RALRP) operations. In this study, we aimed to evaluate the factors affecting postoperative urinary continence and erectile function in patients who underwent RALRP due to localized prostate cancer in our clinic. Materials and Methods: Our study included 439 patients who were diagnosed with stage 1 prostate cancer and underwent RALRP. Patients' age, preoperative prostate-specific antigen (PSA) value, prostate volume, radical prostatectomy material Gleason score, operative time, transperitoneal surgical approach (posterior or anterior), and surgical margin and extraprostatic extension statuses were recorded. Postoperative continence and erectile function status of the patients were questioned and recorded via telephone interviews and in outpatient clinic follow-up. Patients were divided into groups according to postoperative incontinence and erectile dysfunction status and the variables were compared between the groups. Results: There was no statistically significant difference between the continent and incontinent groups in terms of age, preoperative PSA, prostate volume, operative time, postoperative Gleason score, surgical margin status, extraprostatic extension status, or anterior or posterior approach (p>0.05). There was no statistically significant difference between the groups with and without erectile dysfunction in terms of prostate volume, operative time, postoperative Gleason score, surgical margin status, or extraprostatic extension status (p>0.05), while there were statistically significant differences between the 2 groups in terms of age (p

Objective: The aim of this study is to compare the outcomes of patients who underwent simultaneous transurethral resection of the prostate (TURP) and transurethral resection of bladder tumor (TURBT) with those who underwent only TURBT. Design: Historical-cohort Setting: Department of Urology, Ege University School of Medicine, Turkey Subjects: One hundred and eighty-six patients who underwent TUR were included in the study. Intervention: Tumor characteristics, complication, recurrence and progression rates, recurrence localizations, and elapsed time to recurrence were compared between the groups. Main outcome measures: Outcomes of simultaneous resection Results: The bladder tumor recurrence rate was 36.6% for group A and 29.8% for group B (P=.068), and the progression rates were 8.2% and 6.4%, respectively (P=.084). There was no significant difference between the elapsed time to recurrence (8.28 +/- 1.17 vs. 6.54 +/- 1.28 months) and the rate of prostatic urethral recurrence (1.8% vs. 1.7%, P=.712 and P=.395, respectively). Complication rates and progression distribution of tumors were also similar in both groups. Conclusion: It is safe to resect an incidentally detected bladder tumor along with prostate resection, with similar rates of progression, recurrence, and complications.